Artículos del autor

solaci

Day 3

TITAN-AMI: Final results of bio-active coated stent

Previous studies suggest the excellent performance of the bioactive coated stent TITAN 2 compared with drug-eluting stents...
solaci -
Day 3

Safety and efficacy of a new multi-electrode device for simultaneous renal ablation

This study aimed to establish the safety and effectiveness of renal denervation using the new multielectrode device...
solaci -
Day 3

SIMPLICITY HTN -3: subgroup analysis identifies potential confounders

Initial studies showed a blood pressure significant reduction to 3 years in patients with resistant hypertension, while...
solaci -
Day 2

IBERIAN: appendage occlusion registry

The aim of this study was to observe the rate of thromboembolic and hemorrhagic events in a...
solaci -
Day 2

Bivalirudin superior than heparin beyond the use or not of Glycoprotein inhibitors

Bivalirudin benefits in bleeding events versus heparin plus glycoprotein IIbIIIa inhibitors is clear even though  this benefit...
solaci -
Day 2

Meta-analysis confirms the reduction in ischemic events with 2nd generation DES versus BMS

This paper included 5 studies that randomized patients to conventional stent versus chromium cobalt everolimus eluting stent;...
solaci -
Day 2

PARIS register: Non-adherence impact to antiplatelet therapy among men and women

The PARIS registry was a prospective observational study in 5018 patients undergoing coronary angioplasty with stent implantation...
solaci -
Day 2

COMPARE II: biolimus eluting stent with biodegradable polymer versus everolimus at 3 years.

This study randomized 2:1 - 2707 patients to biolimus eluting stent with biodegradable polymer versus everolimus eluting...
solaci -